Cambridge Investment Research Advisors, Inc.

Position in BEAM — Beam Therapeutics Inc.

CIK 1419186 FAIRFIELD, IA

Position in BEAM

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$224,040

+$26,338 QoQ

Shares Held

6,528

-35.5% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#185

of 274 holders

Holding Since

Dec 2020

11 quarters on record

Healthcare · as of Jun 30, 2026

Cambridge Investment Research Advisors, Inc. holds $60,632,692 across 72 Biotechnology names. BEAM ranks #48 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	21,946	$10,901,236
2	EXEL	Exelixis, Inc.	82,212	$4,473,154
3	NKTR	Nektar Therapeutics	56,186	$3,922,344
4	CORT	Corcept Therapeutics Inc	35,157	$3,056,901
5	RVMD	Revolution Medicines, Inc.	15,839	$2,966,327
6	REGN	Regeneron Pharmaceuticals, Inc.	4,591	$2,862,672
7	CRSP	CRISPR Therapeutics AG	46,210	$2,520,293
8	BBIO	BridgeBio Pharma, Inc.	30,727	$2,288,546

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$224,040	6,528	-35.5%	Shares	Sole	2026-07-30
2025-03-31	$197,702	10,123	-4.3%	Shares	Sole	2025-04-22
2024-12-31	$262,334	10,578	+1.4%	Shares	Sole	2025-02-14
2024-09-30	$255,657	10,435	+84.4%	Shares	Sole	2024-10-28
2022-12-31	$221,284	5,658	+3.6%	Shares	Sole	2023-02-08
2022-09-30	$260,162	5,461	+108.8%	Shares	Sole	2022-10-17
2021-12-31	$208,469	2,616	-24.9%	Shares	Sole	2022-02-03
2021-09-30	$303,055	3,483	-54.3%	Shares	Sole	2021-11-02
2021-06-30	$980,641	7,619	+130.0%	Shares	Sole	2021-08-10
2021-03-31	$265,172	3,313	-13.4%	Shares	Sole	2021-05-07
2020-12-31	$312,354	3,826	—	Shares	Sole	2021-02-04
No filing history on record for this holder in this stock.